vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Pangaea Logistics Solutions Ltd. (PANL). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($191.2M vs $183.9M, roughly 1.0× Pangaea Logistics Solutions Ltd.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (57.4% vs 24.9%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (48.1% CAGR vs 32.5%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Pangaea Logistics Solutions Ltd. is a global dry bulk logistics and shipping service provider. It operates a modern fleet of dry bulk vessels to transport a wide range of commodities including grains, minerals, construction materials, and energy-related raw materials, serving industrial, agricultural, and energy sector clients across North America, Europe, and Asia with tailored end-to-end bulk cargo supply chain solutions.
AXSM vs PANL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $191.2M | $183.9M |
| Net Profit | — | $11.9M |
| Gross Margin | — | — |
| Operating Margin | -33.1% | 9.5% |
| Net Margin | — | 6.5% |
| Revenue YoY | 57.4% | 24.9% |
| Net Profit YoY | — | 40.9% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $183.9M | ||
| Q3 25 | $171.0M | $168.7M | ||
| Q2 25 | $150.0M | $156.7M | ||
| Q1 25 | $121.5M | $122.8M | ||
| Q4 24 | $118.8M | $147.2M | ||
| Q3 24 | $104.8M | $153.1M | ||
| Q2 24 | $87.2M | $131.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $11.9M | ||
| Q3 25 | $-47.2M | $12.2M | ||
| Q2 25 | $-48.0M | $-2.7M | ||
| Q1 25 | $-59.4M | $-2.0M | ||
| Q4 24 | $-74.9M | $8.4M | ||
| Q3 24 | $-64.6M | $5.1M | ||
| Q2 24 | $-79.3M | $3.7M |
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 9.5% | ||
| Q3 25 | -27.0% | 10.0% | ||
| Q2 25 | -24.5% | 2.3% | ||
| Q1 25 | -46.9% | 2.4% | ||
| Q4 24 | -61.1% | 10.1% | ||
| Q3 24 | -59.8% | 9.8% | ||
| Q2 24 | -89.5% | 5.8% |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 6.5% | ||
| Q3 25 | -27.6% | 7.2% | ||
| Q2 25 | -32.0% | -1.8% | ||
| Q1 25 | -48.9% | -1.6% | ||
| Q4 24 | -63.1% | 5.7% | ||
| Q3 24 | -61.7% | 3.3% | ||
| Q2 24 | -91.0% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $0.18 | ||
| Q3 25 | $-0.94 | $0.19 | ||
| Q2 25 | $-0.97 | $-0.04 | ||
| Q1 25 | $-1.22 | $-0.03 | ||
| Q4 24 | $-1.54 | $0.19 | ||
| Q3 24 | $-1.34 | $0.11 | ||
| Q2 24 | $-1.67 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $305.1M | $103.1M |
| Total DebtLower is stronger | $70.0M | $249.6M |
| Stockholders' EquityBook value | — | $429.3M |
| Total Assets | $713.6M | $928.1M |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $103.1M | ||
| Q3 25 | $325.3M | $94.0M | ||
| Q2 25 | $303.0M | $59.3M | ||
| Q1 25 | $300.9M | $63.9M | ||
| Q4 24 | $315.4M | $86.8M | ||
| Q3 24 | $327.3M | $93.1M | ||
| Q2 24 | $315.7M | $77.9M |
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | $249.6M | ||
| Q3 25 | — | $256.2M | ||
| Q2 25 | — | $244.7M | ||
| Q1 25 | — | $251.0M | ||
| Q4 24 | — | $257.2M | ||
| Q3 24 | — | $133.6M | ||
| Q2 24 | — | $90.5M |
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $429.3M | ||
| Q3 25 | $73.7M | $420.3M | ||
| Q2 25 | $73.1M | $414.4M | ||
| Q1 25 | $53.2M | $420.8M | ||
| Q4 24 | $57.0M | $427.8M | ||
| Q3 24 | $92.9M | $332.6M | ||
| Q2 24 | $102.9M | $331.5M |
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $928.1M | ||
| Q3 25 | $669.3M | $932.1M | ||
| Q2 25 | $639.8M | $916.0M | ||
| Q1 25 | $596.7M | $918.0M | ||
| Q4 24 | $568.5M | $936.5M | ||
| Q3 24 | $561.5M | $749.2M | ||
| Q2 24 | $548.2M | $692.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $15.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $15.1M | ||
| Q3 25 | $1.0M | $28.6M | ||
| Q2 25 | $-32.4M | $14.4M | ||
| Q1 25 | $-43.4M | $-4.4M | ||
| Q4 24 | $-26.2M | $19.3M | ||
| Q3 24 | $-18.6M | $28.5M | ||
| Q2 24 | $-30.1M | $9.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | 5.57× | ||
| Q2 24 | — | 2.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
PANL
| Voyage | $166.3M | 90% |
| Charter | $13.1M | 7% |
| Terminal Stevedore Revenue | $4.4M | 2% |
